Home » Orexigen Obesity Drug Contrave Filed in Europe
Orexigen Obesity Drug Contrave Filed in Europe
Orexigen has filed for approval of its obesity drug Contrave with the European Medicines Agency, hoping to market the drug in early 2015.
Pharma Times
Pharma Times
Upcoming Events
-
07May
-
14May
-
30May